2
@IRDiRC [email protected] www.irdirc.org Get in touch Vision Enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention International level co-operation to stimulate, better coordinate and maximize output of rare disease research efforts around the world Goal : Promote the use of research resources already available and adopted by the rare diseases research community Resources : Evaluated via a peer-reviewed process by IRDiRC Scientific Committees and experts in the field Applications : Accepted on a rolling basis More information can be found at: http://www.irdirc.org/research/irdirc-recognized-resources/ A public label and quality indicator to designate resources (platforms, tools, standards, and guidelines) of fundamental importance to the international RD research community. 58 members from 21 different countries

IRDIRC Leaflet FV · 2020. 3. 23. · @IRDiRC [email protected] Getin touch Vision Enableallpeoplelivingwithararediseasetoreceivean accuratediagnosis,care

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: IRDIRC Leaflet FV · 2020. 3. 23. · @IRDiRC scientificsupport@irdirc.org  Getin touch Vision Enableallpeoplelivingwithararediseasetoreceivean accuratediagnosis,care

@IRDiRC

[email protected]

www.irdirc.org

Get in touch

VisionEnable all people living with a rare disease to receive anaccurate diagnosis, care, and available therapy withinone year of coming to medical attention

International level co-operation to stimulate, better coordinate and maximize output of rare disease research efforts around the world

Goal: Promote the use of research resources already available and adopted by the rare diseases research communityResources: Evaluated via a peer-reviewed process by IRDiRC Scientific Committees and experts in the fieldApplications: Accepted on a rolling basisMore information can be found at: http://www.irdirc.org/research/irdirc-recognized-resources/

A public label and

quality indicator to designate resources

(platforms, tools,

standards, and guidelines) of fundamental

importance to the international RD

research community.

58 members from21 different countries

Page 2: IRDIRC Leaflet FV · 2020. 3. 23. · @IRDiRC scientificsupport@irdirc.org  Getin touch Vision Enableallpeoplelivingwithararediseasetoreceivean accuratediagnosis,care

Funding organizations and companies invest more than $10

mln in 5 years in research projectsPatient organizations represent the

broad patients’ interests for all rare diseases

Develop the means to diagnose patients with suspected rare diseaseswithin one year of coming to medical attentionDevelop 1,000 new therapies for rare diseases, and particularly fordiseases with no approved treatmentCreate methods for assessing the impact of diagnoses and therapies onrare disease patients

Orphan Drug DevelopmentGuidebook

Patient Engagement in Research

Model Consent ClausesFor Rare Disease Research

Small PopulationClinical Trials

Patient-CenteredOutcome Measures

Automatable Discoveryand Access

Matchmaker Exchange

Privacy-PreservingRecord Linkage

Data Mining andRepurposing

2015 2016 2017 2018 2019

Solving the Unsolved

S2 S1 S2 S1 S2 S1 S2 S1 S2

Indigenous Population

Clinical ResearchNetworks

Task Forces are created to tackle specific time-limited topics within rare diseases research proposed by the Consortium’s Constituent and/or Scientific CommitteesTask Forces develop solutions through policy recommendations and/or technical applications including platforms, tools, standards and guidelines

IRDiRC recruits experts and key players throughout the world to populateits Scientific Committees and Task Forces.The Task Forces may operate either solely as IRDiRC initiatives or jointlywith partner groups that wish to collaborate and address similar issues.

Companies Funders

Patient Advocates

Interdisciplinary

Diagnostic Therapies

Members

IRDiRC goals by 2027IRDiRC organizes several activities and provides many resources

to the international rare diseases research community

IRDiRC activities & resources

Members have balancedexpertises and represent

academia, patient organizations, diagnostics, pharmaceutical

industry, and regulatory bodies

Constituent Committees Scientific Committees

Task Forces Working

Groups

Publications

Conferences &

Workshops

Meeting ReportsGene

Counter

Orphan Drug

Counter

State of Play

Policies & Guidelines

Recognized Resources

IRDiRC Task Forces